He injected another man with a lethal dose of fentanyl after learning the victim was cooperating in a shooting investigation ...

The drug will be offered alongside cholesterol-lowering statins and blood pressure medication, as well as diet and lifestyle ...

The NHS has announced it will make the life-changing jab available to an additional 1.2m people as a health prevention ...

Novo Nordisk launched a new discounted subscription program for its Wegovy obesity drugs in the U.S. as it tries to win customers by offering a lower, predictable monthly price.

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new ...

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as ...

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could ...

The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, ...

Kentucky Attorney General Russell Coleman argued Monday for the dismissal of a 2006 case that's at the center of a 16-year ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.

The FDA has some big verdicts lined up in the second quarter, including one for a closely watched obesity drug that many anticipate will further intensify competition in weight loss.